(Q45944908)

English

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.

scientific article published in July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

1 reference

based on heuristic

inferred from title

Bernardo Rapoport

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

author name string

Karin Jordan

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Judith A Boice

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Arlene Taylor

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Carole Brown

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

James S Hardwick

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Alexandra Carides

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Timothy Webb

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Hans-Joachim Schmoll

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

18

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

423-431

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

https://scigraph.springernature.com/pub.10.1007/s00520-009-0680-9

0 references

Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for classifying the acute emetogenicity of cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antiemetic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19568773

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-009-0680-9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19568773

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45944908&oldid=1403675254"